AVEO Pharmaceuticals CEO Michael Bailey's 2019 pay falls 49% to $1.6M

AVEO Pharmaceuticals reports 2019 executive compensation

By ExecPay News

Published: April 28, 2020

AVEO Pharmaceuticals reported fiscal year 2019 executive compensation information on April 28, 2020.
In 2019, three executives at AVEO Pharmaceuticals received on average a compensation package of $1M, a 35% decrease compared to previous year.
Average pay of disclosed executives at AVEO Pharmaceuticals
Michael Bailey, Chief Executive Officer, received $1.6M in total, which decreased by 49% compared to 2018. 46% of Bailey's compensation, or $735K, was in option awards. Bailey also received $258K in non-equity incentive plan, $528K in salary, as well as $69K in other compensation.
For fiscal year 2019, the median employee pay was $283,507 at AVEO Pharmaceuticals. Therefore, the ratio of Michael Bailey's pay to the median employee pay was 6 to one.
Karuna Rubin, General Counsel, received a compensation package of $749K, which decreased by 25% compared to previous year. 46% of the compensation package, or $345K, was in salary.
Michael Needle, Chief Medical Officer, earned $720K in 2019, a 35% decrease compared to previous year.

Related executives

Michael Bailey

AVEO Pharmaceuticals

Chief Executive Officer

Michael Needle

AVEO Pharmaceuticals

Chief Medical Officer

Karuna Rubin

AVEO Pharmaceuticals

General Counsel

You may also like

Source: SEC filing on April 28, 2020.